Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 484361 - 484380 out of 485022 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EA03) nilotinib (adm: O) | TASIGNA 50MG CAP,ORAL | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA06) asciminib (adm: O) | SCEMBLIX 100MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA06) asciminib (adm: O) | SCEMBLIX 100MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA06) asciminib (adm: O) | SCEMBLIX 20MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA06) asciminib (adm: O) | SCEMBLIX 20MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA06) asciminib (adm: O) | SCEMBLIX 40MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA06) asciminib (adm: O) | SCEMBLIX 40MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EC02) dabrafenib (adm: O) | TAFINLAR 50MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
| USA | (L01EC02) dabrafenib (adm: O) | TAFINLAR 50MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
| USA | (L01EC02) dabrafenib (adm: O) | TAFINLAR 75MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
| USA | (L01EC02) dabrafenib (adm: O) | TAFINLAR 75MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
| USA | (L01EC02) dabrafenib (adm: O) | TAFINLAR 10MG TAB,SUSP,ORAL | 210 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
| USA | (L01EC02) dabrafenib (adm: O) | TAFINLAR 10MG TAB,SUSP,ORAL | 210 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
| USA | (L01ED02) ceritinib (adm: O) | ZYKADIA 150MG TAB | 84 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NovartisPharmaceuticalsCorporation |
| USA | (L01ED02) ceritinib (adm: O) | ZYKADIA 150MG TAB | 84 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NovartisPharmaceuticalsCorporation |
| USA | (L01EE01) trametinib (adm: O) | MEKINIST 0.05MG/ML SOLN,ORAL | 90ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
| USA | (L01EE01) trametinib (adm: O) | MEKINIST 0.05MG/ML SOLN,ORAL | 90ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
| USA | (L01EE01) trametinib (adm: O) | MEKINIST 0.5MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
| USA | (L01EE01) trametinib (adm: O) | MEKINIST 0.5MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
| USA | (L01EE01) trametinib (adm: O) | MEKINIST 2MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Melanoma | NovartisPharmaceuticalsCorporation |
Pages
